Schellings, M W M <br/><br/>
Determination of dabigatran and rivaroxaban by ultra-performance liquid chromatography-tandem mass spectrometry and coagulation assays after major orthopaedic surgery.  [electronic resource] 

 -  Thrombosis research  Mar 2016 
 - 128-34 p.  digital 
<br/><br/> Publication Type: Clinical Trial; Journal Article 
<br/><br/><label>ISSN: </label>1879-2472 
<br/><br/><label>Standard No.: </label>10.1016/j.thromres.2016.01.012  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Aged<br/>Aged, 80 and over<br/>Anticoagulants--blood<br/>Blood Coagulation--drug effects<br/>Chromatography, High Pressure Liquid--methods<br/>Dabigatran--blood<br/>Drug Monitoring--methods<br/>Female<br/>Humans<br/>Male<br/>Middle Aged<br/>Orthopedic Procedures--adverse effects<br/>Rivaroxaban--blood<br/>Tandem Mass Spectrometry--methods<br/>Venous Thromboembolism--etiology